Full-Time

Senior Scientist I

Vir Biotechnology

Vir Biotechnology

501-1,000 employees

Immunology company developing treatments for infectious diseases.

Data & Analytics

$164,000 - $216,000

Bonus, Equity

Senior, Expert

San Francisco, CA, USA

Required Skills
Google Cloud Platform
Requirements
  • PhD with 5+ years /MS and 8+ years/BS and 10+ years of industry experience.
  • Experience must include a combination of laboratory and project management skills, including managing CROs for assay development and validation for clinical and non-clinical studies.
  • Demonstrated expertise in GLP and GCP compliance of sample handling and storage, bioanalytical assay development, sample analysis, and laboratory operation and procedures is required.
  • Technical expertise with several platforms to analyze all aspects of large molecule therapeutics, including those with complex sample handling and preparation procedures (e.g., enzymatic assays, ligand-binding assays, cell-based assays) from a variety of biological matrices (e.g., serum, plasma).
  • Familiar with PK and PD principles of establishment of relevant assays and assay ranges.
Responsibilities
  • Develop bioanalytical methods to support large molecule clinical candidates and providing bioanalytical input across all departments and stages of research and development.
  • Coordinate method development and analysis activities within the context of development plans.
  • Perform troubleshooting and evaluation of a variety of complex methods to identify appropriate bioanalytical solutions.
  • Lead technology transfer of bioanalytical methods.
  • Interact with internal Research, CMC, Operational, and Regulatory groups to support drug development activities.
  • Responsible for approval of data and reports from external vendors.

Vir Biotechnology, Inc. stands out as a commercial-stage immunology company that leverages advanced technologies and deep immunologic insights to combat serious infectious diseases, with a development pipeline that includes treatments for COVID-19, hepatitis B and D, influenza A, and HIV. The company fosters a culture of equality, inclusion, and respect, believing that the success of its mission is driven by the success of its colleagues. Recognized as the fastest-growing company in North America on the 2022 Deloitte Technology Fast 500™, Vir Biotechnology, Inc. demonstrates industry leadership and a strong competitive edge.

Company Stage

Grant

Total Funding

$908.6M

Headquarters

San Francisco, California

Founded

2016

Growth & Insights
Headcount

6 month growth

2%

1 year growth

2%

2 year growth

29%

Benefits

Comprehensive healthcare coverage

Employer matched 401(k)

Employee stock purchase plan

Childcare assistance

Tuition reimbursement